Report #2826369

Received Feb 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 27 yrs
State: CO
Recovered: Unknown
Vaccinated: Jan 17, 2025
Onset: Jan 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (NO BRAND NAME)	UNKNOWN MANUFACTURER	1	AREXVY (PF) 120	IM / LA

Symptoms (2)

Exposure during pregnancyProduct use issue

Symptom narrative

Arexvy is not indicated for pregnant women at 31-32 weeks At the time patient was 31-32 weeks along.

Other medications

AREXVY (PF) 120 MCG/0.5 ML IM SUSPENSION - INJECT 0.5 MILLILITER (120 MCG) BY INTRAMUSCULAR ROUTE ONCE RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF Site: Deltoid, Left Qty: (0.5) mL Adm